Prescribed Daily Doses (PDDs) of hypolipidaemic agents with emphasis on HMG CoA reductase inhibitors
- At: 2013 FIP Congress in Dublin (Ireland)
- Type: Poster
- By: TRUTER, Ilse (Drug Utilization Research Unit (DURU), Nelson Mandela Metropolitan University, Department of Pharmacy, Port Elizabeth, South Africa)
Dyslipidaemia is a major cardiovascular risk factor in the South African population.
To determine the prescribing patterns of hypolipidaemic agents on the South African market with specific emphasis on the Prescribed Daily Doses (PDDs) of HMG CoA reductase inhibitors (statins).
A retrospective, cross-sectional.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.